IT Link : Close to an important medium term support level
Entry price | Target | Stop-loss | Potential |
---|
€26.2 |
€31.3 |
€24.8 |
+19.47% |
---|
The selling pressure regarding IT Link shares could subside shortly. In fact, the support area that is currently being tested around 25.4 EUR has come into play and could, at least in the short term, keep the downside pressure at bay.
Summary● The company has strong fundamentals. More than 70% of companies have a lower mix of growth, profitability, debt and visibility.
Strengths● The company shows low valuation levels, with an enterprise value at 0.72 times its sales.
● Over the last twelve months, the sales forecast has been frequently revised upwards.
● For the last twelve months, analysts have been gradually revising upwards their EPS forecast for the upcoming fiscal year.
● The difference between current prices and the average target price is rather important and implies a significant appreciation potential for the stock.
● Analysts' price targets are all relatively close, reflecting good visibility on the company's valuation.
● Historically, the company has been releasing figures that are above expectations.
Weaknesses● As a percentage of sales and without taking into account depreciation and amortization, the company has relatively low margins.
The content herein constitutes a general investment recommendation, prepared in accordance with provisions aimed at preventing market abuse by Surperformance, the publisher of MarketScreener.com. More specifically, this recommendation is based on factual elements and expresses a sincere, complete, and balanced opinion. It relies on internal or external data, considered reliable as of the date of their release. Nevertheless, this information, and the resulting recommendation, may contain inaccuracies, errors, or omissions, for which Surperformance cannot be held responsible. This recommendation, which in no way constitutes investment advice, may not be suitable for all investor profiles. The reader acknowledges and accepts that any investment in a financial instrument involves risks, for which they assume full responsibility, without recourse against Surperformance. Surperformance commits to disclosing any conflict of interest that may affect the objectivity of its recommendations.